Hormone pills in menopause may carry gallstone side effects - Fox 28: South Bend, Elkhart IN News, Weather, Sports

Hormone pills in menopause may carry gallstone side effects

Updated:
© iStockphoto.com © iStockphoto.com
  • Local Health Services

  • Education, screening, and early detection of breast cancer are important weapons against Breast Cancer.  The Memorial Regional Breast Care Center provides you with all of the tools necessary to maintain good breast health.
    At the Memorial Regional Breast Care Center, our emphasis is on wellness and providing you with all of the tools necessary to maintain good breast health. Education, screening, and early detection of breast cancer are important weapons against the disease.
  • External Beam Radiation Therapy, IMRT and 3D Treatment Planning, Respiratory Gating, Stereotactic Radiotherapy, Prostate Treatments, Mammosite, and more...
    External Beam Radiation Therapy, IMRT and 3D Treatment Planning, Respiratory Gating, Stereotactic Radiotherapy, Prostate Treatments, Mammosite, and more...
  • Trips to Indianapolis were routine for Michiana children diagnosed with cancer & blood disorders. The Pediatric Hematology/Oncology Program at Memorial Hospital provides many of the same essential services close to home.
    Frequent trips to Indianapolis were routine for Michiana children diagnosed with cancer and blood disorders. But today, the Pediatric Hematology/ Oncology Program at Memorial Hospital provides many of the same essential services close to home.

TUESDAY, March 19 (HealthDay News) -- Taking estrogen pills increases a menopausal woman's risk of needing gallbladder surgery to treat complications of gallstones, according to a new study.

But there does not appear to be an increased risk for women who take estrogen through skin patches or gels, called transdermal methods.

The study appears March 18 in the CMAJ (Canadian Medical Association Journal).

Researchers analyzed data gathered from more than 70,000 women in France between 1992 and 2008. In France, transdermal hormone therapy is preferred, while oral hormone therapy (pills or tablets) tends to be favored in North America and the United Kingdom, a journal news release noted.

"Complicated gallstone disease should be added to the list of potential adverse events to be considered when balancing the benefits and risks associated with menopausal hormone therapy," said Dr. Antoine Racine, of the French National Institute for Health and Medical Research and Paris-Sud University, and colleagues.

These findings support current recommendations for minimizing doses and duration of hormone therapy to treat symptoms of menopause, Dr. Bette Liu, of the faculty of medicine at the University of New South Wales, in Sydney, Australia, wrote in an accompanying editorial.

If hormone therapy is necessary, skin patches or gels may cause fewer side effects than pills or tablets, she added.

"Unfortunately there are no large clinical trials comparing transdermal and oral therapies, and such trials will probably never be conducted," Liu wrote. "Evidence to guide recommendations on the best route of hormone administration for individual women and prescribers will thus be limited to the growing volume of observational data. These data suggest that the overall risk-benefit of transdermal menopausal hormone therapy makes it a more attractive option than oral therapies."

Although the study showed a link between oral estrogen medications and gallbladder complications, it did not establish a cause-and-effect relationship.

More information

The U.S. National Institute on Aging has more about hormones and menopause.

Health News Copyright © 2013 HealthDay. All rights reserved.

*DISCLAIMER*: The information contained in or provided through this site section is intended for general consumer understanding and education only and is not intended to be and is not a substitute for professional advice. Use of this site section and any information contained on or provided through this site section is at your own risk and any information contained on or provided through this site section is provided on an "as is" basis without any representations or warranties.
  • Memorial Regional Cancer Center - Meet Our DoctorsMemorial Regional Cancer Center - Meet Our Doctors

  • David Hornback, M.D., received his medical degree and completed his residency in radiation oncology at Indiana University School of Medicine, and servedhis internship through the Transitional Residency
    David Hornback, M.D., received his medical degree and completed his residency in radiation oncology at Indiana University School of Medicine, and servedhis internship through the Transitional Residency
  • Dr. Kelly received his medical degree from Northwestern Medical School in 1973 and completed residencies in general surgery and cardiothoracic surgery at the Barnes Hospital-Washington University School of Medicine in 1981.
  • Dr. Maher received his bachelor's degree from the University of Illinois and his medical degree from The Chicago College of Osteopathic Medicine (Midwestern University).
    Dr. Maher received his bachelor's degree from the University of Illinois and his medical degree from The Chicago College of Osteopathic Medicine (Midwestern University). Postgraduate training included a pediatric residency at Tripler Army Medical Center in Honolulu and a fellowship in pediatric hematology/oncology at Walter Reed Army Medical Center
Powered by WorldNow

Fox 28

WSJV-TV FOX 28
58096 County Road 7, South
Elkhart, IN 46517

Switchboard: 574.679.9758
News Phone: 574.679.4545
Station Fax: 574.294.1267
Email: fox28news@fox28.com

All content ©Copyright 2000 - 2013 WorldNow and WSJV. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.

Persons with disabilities who need assistance with issues relating to the content of this station's public inspection file should contact Administrative Assistant Heather Stewart at (574) 343-5310. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, at 888-835-5322 (TTY) or at fccinfo@fcc.gov.